3 min read
FDA’s Draft Guidance for Data Monitoring Committees (DMCs)
How Veristat’s Proven DMC Expertise for Complex Trials Supports Patient Safety and Sponsor Success
Home >
Blog
Blog | Veristat, The Science-First CRO
Gain the latest insights and trends in clinical trials, patient recruitment, data analysis, adaptive design, regulatory submissions and approvals.
Sign Up Today
Clinical Trial Regulations (3)
4 min read
Monthly FDA Guidance and Regulatory News Review - July 2024
August 28, 2024
Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance updates from the US Food & Drug Administration (FDA) that are pertinent to the governance of clinical trials and drug, biologic, or medical device development...
4 min read
Monthly FDA Guidance and Regulatory News Review - June 2024
July 8, 2024
Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance updates from the US Food & Drug Administration (FDA) that are pertinent to the governance of clinical trials and drug, biologic, or medical device development...
2 min read
Monthly FDA Guidance and Regulatory News Review - May 2024
June 12, 2024
Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance updates from the US Food & Drug Administration (FDA) that are pertinent to the governance of clinical trials and drug, biologic, or medical device development...
5 min read
Monthly FDA Guidance and Regulatory News Review - April 2024
May 22, 2024
Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance updates from the US Food & Drug Administration (FDA) that are pertinent to the governance of clinical trials and drug, biologic, or medical device development...
4 min read
Monthly FDA Guidance and Regulatory News Review - March 2024
April 24, 2024
Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance updates from the US Food & Drug Administration (FDA) that are pertinent to the governance of clinical trials and drug, biologic, or medical device development...
4 min read
Regulatory Guidance Monthly Review - February 2024
March 12, 2024
Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance updates from the US Food & Drug Administration (FDA) that are pertinent to the governance of clinical trials and drug, biologic, or medical device development...
2 min read
Regulatory Guidance Monthly Review - January 2024
February 14, 2024
Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance updates from the US Food & Drug Administration (FDA) that are pertinent to the governance of clinical trials and drug, biologic, or medical device development...
3 min read
Regulatory Guidance Monthly Review - December 2023
January 17, 2024
Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance updates from the US Food & Drug Administration (FDA) that are pertinent to the governance of clinical trials and drug, biologic, or medical device development...
3 min read
Regulatory Guidance Monthly Review - November 2023
December 13, 2023
Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance updates from the US Food & Drug Administration (FDA) that are pertinent to the governance of clinical trials and drug, biologic, or medical device development...